{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:14:21Z","timestamp":1760382861490},"reference-count":37,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,1,30]]},"DOI":"10.1536\/ihj.20-182","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T22:06:16Z","timestamp":1608933976000},"page":"9-15","source":"Crossref","is-referenced-by-count":7,"title":["Increased Circulating Cathepsin L in Patients with Coronary Artery Disease"],"prefix":"10.1536","volume":"62","author":[{"given":"Chenglin","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiongjie","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minglong","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pathophysiology, Jiaxing University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianwu","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hypertension, Yanbian University Hospital"},{"name":"Department of Physiology and Pathophysiology, Jiaxing University Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Cheng XW, Huang Z, Kuzuya M, Okumura K, Murohara T. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications. Hypertension 2011; 58: 978-86.","DOI":"10.1161\/HYPERTENSIONAHA.111.180935"},{"key":"2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.111.066712","volume":"125","year":"2012","unstructured":"2. Cheng XW, Shi GP, Kuzuya M, Sasaki T, Okumura K, Murohara T. Role for cysteine protease cathepsins in heart disease: Focus on biology and mechanisms with clinical implication. Circulation 2012; 125: 1551-62.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Wu H, Du Q, Dai Q, Ge J, Cheng X. Cysteine protease cathepsins in atherosclerotic cardiovascular diseases. J Atheroscler Thromb 2018; 25: 111-23.","DOI":"10.5551\/jat.RV17016"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hu L, Cheng XW, Song H, <i>et al<\/i>. Cathepsin k activity controls injury-related vascular repair in mice. Hypertension 2014; 63: 607-15.","DOI":"10.1161\/HYPERTENSIONAHA.113.02141"},{"key":"5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.HYP.0000242331.99369.2f","volume":"48","year":"2006","unstructured":"5. Cheng XW, Obata K, Kuzuya M, <i>et al<\/i>. Elastolytic cathepsin induction\/activation system exists in myocardium and is upregulated in hypertensive heart failure. Hypertension 2006; 48: 979-87.","journal-title":"Hypertension","ISSN":"http:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wu H, Cheng XW, Hu L, <i>et al<\/i>. Cathepsin s activity controls injury-related vascular repair in mice via the tlr2-mediated p38mapk and pi3k-akt\/p-hdac6 signaling pathway. Arterioscler Thromb Vasc Biol 2016; 36: 1549-57.","DOI":"10.1161\/ATVBAHA.115.307110"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Fujita M, Cheng XW, Inden Y, <i>et al<\/i>. Mechanisms with clinical implications for atrial fibrillation-associated remodeling: Cathepsin k expression, regulation, and therapeutic target and biomarker. J Am Heart Assoc 2013; 2: e000503.","DOI":"10.1161\/JAHA.113.000503"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Wang H, Meng X, Piao L, <i>et al<\/i>. Cathepsin s deficiency mitigated chronic stress-related neointimal hyperplasia in mice. J Am Heart Assoc 2019; 8: e011994.","DOI":"10.1161\/JAHA.119.011994"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Li X, Cheng XW, Hu L, <i>et al<\/i>. Cathepsin s activity controls ischemia-induced neovascularization in mice. Int J Cardiol 2015; 183: 198-208.","DOI":"10.1016\/j.ijcard.2015.01.058"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sun J, Sukhova GK, Zhang J, <i>et al<\/i>. Cathepsin k deficiency reduces elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 2012; 32: 15-23.","DOI":"10.1161\/ATVBAHA.111.235002"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Abd-Elrahman I, Meir K, Kosuge H, <i>et al<\/i>. Characterizing cathepsin activity and macrophage subtypes in excised human carotid plaques. Stroke 2016; 47: 1101-8.","DOI":"10.1161\/STROKEAHA.115.011573"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Klaus V, Schmies F, Reeps C, <i>et al<\/i>. Cathepsin s is associated with degradation of collagen i in abdominal aortic aneurysm. Vasa 2018; 47: 285-93.","DOI":"10.1024\/0301-1526\/a000701"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Yang G, Lei Y, Inoue A, <i>et al<\/i>. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in apoe-deficient mice under chronic stress. Atherosclerosis 2017; 264: 1-10.","DOI":"10.1016\/j.atherosclerosis.2017.07.014"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Lei Y, Yang G, Hu L, <i>et al<\/i>. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in apoe-deficient mice under chronic stress. Int J Cardiol 2017; 243: 413-20.","DOI":"10.1016\/j.ijcard.2017.05.062"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Liu J, Sukhova GK, Yang JT, <i>et al<\/i>. Cathepsin l expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. Atherosclerosis 2006; 184: 302-11.","DOI":"10.1016\/j.atherosclerosis.2005.05.012"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cheng XW, Sasaki T, Kuzuya M. The role of cysteinyl cathepsins in venous disorders. Thromb Haemost 2014; 112: 216-8.","DOI":"10.1160\/TH13-10-0889"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Liu CL, Guo J, Zhang X, Sukhova GK, Libby P, Shi GP. Cysteine protease cathepsins in cardiovascular disease: From basic research to clinical trials. Nat Rev Cardiol 2018; 15: 351-70.","DOI":"10.1038\/s41569-018-0002-3"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Feldreich T, Carlsson AC, Riserus U, Larsson A, Lind L, Arnlov J. The association between serum cathepsin l and mortality in older adults. Atherosclerosis 2016; 254: 109-16.","DOI":"10.1016\/j.atherosclerosis.2016.09.062"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Veillard F, Saidi A, Burden RE, <i>et al<\/i>. Cysteine cathepsins s and l modulate anti-angiogenic activities of human endostatin. J Biol Chem 2011; 286: 37158-67.","DOI":"10.1074\/jbc.M111.284869"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Urbich C, Heeschen C, Aicher A, <i>et al<\/i>. Cathepsin l is required for endothelial progenitor cell-induced neovascularization. Nat Med 2005; 11: 206-13.","DOI":"10.1038\/nm1182"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Cai J, Zhong H, Wu J, <i>et al<\/i>. Cathepsin l promotes vascular intimal hyperplasia after arterial injury. Mol Med 2017; 23: 92-100.","DOI":"10.2119\/molmed.2016.00222"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kitamoto S, Sukhova GK, Sun J, <i>et al<\/i>. Cathepsin l deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice. Circulation 2007; 115: 2065-75.","DOI":"10.1161\/CIRCULATIONAHA.107.688523"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Sun J, Sukhova GK, Zhang J, <i>et al<\/i>. Cathepsin l activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 2011; 31: 2500-8.","DOI":"10.1161\/ATVBAHA.111.230201"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-43.","DOI":"10.1161\/hc0902.104353"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Shi GP, Sukhova GK, Grubb A, <i>et al<\/i>. Cystatin c deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104: 1191-7.","DOI":"10.1172\/JCI7709"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Li X, Li Y, Jin J, <i>et al<\/i>. Increased serum cathepsin k in patients with coronary artery disease. Yonsei Med J 2014; 55: 912-9.","DOI":"10.3349\/ymj.2014.55.4.912"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Chatzizisis YS, Baker AB, Sukhova GK, <i>et al<\/i>. Augmented expression and activity of extracellular matrix-degrading enzymes in regions of low endothelial shear stress colocalize with coronary atheromata with thin fibrous caps in pigs. Circulation 2011; 123: 621-30.","DOI":"10.1161\/CIRCULATIONAHA.110.970038"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Geluk CA, Post WJ, Hillege HL, <i>et al<\/i>. C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: Data from the prospective prevend cohort. Atherosclerosis 2008; 196: 372-82.","DOI":"10.1016\/j.atherosclerosis.2006.11.013"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hermus L, Lefrandt JD, Tio RA, Breek JC, Zeebregts CJ. Carotid plaque formation and serum biomarkers. Atherosclerosis 2010; 213: 21-9.","DOI":"10.1016\/j.atherosclerosis.2010.05.013"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Lutgens E, Lutgens SP, Faber BC, <i>et al<\/i>. Disruption of the cathepsin k gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 2006; 113: 98-107.","DOI":"10.1161\/CIRCULATIONAHA.105.561449"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sukhova GK, Zhang Y, Pan JH, <i>et al<\/i>. Deficiency of cathepsin s reduces atherosclerosis in ldl receptor-deficient mice. J Clin Invest 2003; 111: 897-906.","DOI":"10.1172\/JCI200314915"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Sasaki T, Kuzuya M, Nakamura K, <i>et al<\/i>. At1 blockade attenuates atherosclerotic plaque destabilization accompanied by the suppression of cathepsin s activity in apoe-deficient mice. Atherosclerosis 2010; 210: 430-7.","DOI":"10.1016\/j.atherosclerosis.2009.12.031"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Sasaki T, Kuzuya M, Nakamura K, <i>et al<\/i>. A simple method of plaque rupture induction in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2006; 26: 1304-9.","DOI":"10.1161\/01.ATV.0000219687.71607.f7"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Fukuda D, Shimada K, Tanaka A, <i>et al<\/i>. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 2006; 97: 175-80.","DOI":"10.1016\/j.amjcard.2005.08.020"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Oorni K, Sneck M, Bromme D, <i>et al<\/i>. Cysteine protease cathepsin f is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro. J Biol Chem 2004; 279: 34776-84.","DOI":"10.1074\/jbc.M310814200"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Lutgens SP, Cleutjens KB, Daemen MJ, Heeneman S. Cathepsin cysteine proteases in cardiovascular disease. FASEB J 2007; 21: 3029-41.","DOI":"10.1096\/fj.06-7924com"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Lindstedt L, Lee M, Oorni K, Bromme D, Kovanen PT. Cathepsins f and s block hdl3-induced cholesterol efflux from macrophage foam cells. Biochem Biophys Res Commun 2003; 312: 1019-24.","DOI":"10.1016\/j.bbrc.2003.11.020"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-182\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T03:53:42Z","timestamp":1611978822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/1\/62_20-182\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-182","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]}}}